Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation

Journal of Lipid Research

Volumn 46, Issue 9, 2005, Pages 1923-1932

  Androulakis, Nicolaos ^a   Durand, Hervé ^b   Ninio, Ewa ^b   Tsoukatos, Demokritos C ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b INSERM   (France)

Author keywords

Atherogenesis; Low density lipoprotein; Mediators of inflammation; Oxidized phospholipids; Platelet activating factor acetylhydrolase; Platelet activating factor transacetylase

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; 1 O ALKYLGLYCERO 3 PHOSPHORYLCHOLINE; LOW DENSITY LIPOPROTEIN; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN CELL; INFLAMMATION; LIPID OXIDATION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; PLATELET ACTIVATING FACTOR; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 24344435114     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M500074-JLR200     Document Type: Article

References (46)

1. Ross, R. 1999. Mechanism of disease: atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340: 115-126.
2. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
3. Camejo, G., E. Hurt-Camejo, U. Olsson, and G. Bondjers. 1993. Proteoglycans and lipoproteins in atherosclerosis. Curr. Opin. Lipidol. 4: 385-391.
4. Steinberg, D. 1997. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272: 20963-20966.
5. Berliner, J. A., M. Navab, A. M. Fogelman, J. S. Frank, L. L. Demer, P. A. Edwards, A. D. Watson, and A. J. Lusis. 1995. Atherosclerosis: basic mechanisms, oxidation, inflammation, and genetics. Circulation. 91: 2488-2496.
6. Prescott, S. M., G. A. Zimmerman, D. M. Stafforini, and T. M. McIntyre. 2000. Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 69: 419-445.
7. Ninio, E. 2005. Phospholipid mediators in the vessel wall: involvement in atherosclerosis. Curr. Opin. Clin. Nutr. Metab. Care. 8: 123-131.
8. Honda, Z., M. Nakamura, I. Miki, M. Minami, T. Watanabe, Y. Seyama, H. Okado, H. Toh, K. Ito, T. Miyamoto, et al. 1991. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature. 349: 342-346.
9. Izumi, T., and T. Shimizu. 1995. Platelet-activating factor receptor: gene expression and signal transduction. Biochim. Biophys. Acta. 1259: 317-333.
10. Kamido, H., A. Kuksis, L. Marai, and J. J. Myher. 1995. Lipid ester-bound aldehydes among cooper-catalyzed peroxidation products of human plasma lipoproteins. J. Lipid Res. 36: 1876-1886.
11. Tokumura, A., M. Toujima, Y. Yoshioka, and K. Fukuzawa. 1996. Lipid peroxidation in low density lipoproteins from human plasma and egg yolk promotes accumulation of 1-acyl analogues of platelet activating factor like lipids. Lipids. 31: 11251-11258.
12. Heery, J. M., M. Kozak, D. M. Stafforini, D. A. Jones, G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. 1995. Oxidatively modified LDL contains phospholipids with platelet activating factor like activity and stimulates the growth of smooth muscle cells. J. Clin. Invest. 96: 2322-2330.
13. Smiley, P. L., K. E. Stremler, S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. 1991. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor. J. Biol. Chem. 266: 11104-11110.
14. Subbanagunder, G., N. Leitinger, P. T. Shih, K. F. Faull, and J. A. Berliner. 1999. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis: in vitro and in vivo inhibition by WEB 2086. Circ. Res. 85: 311-318.
15. Six, D. A., and E. A. Dennis. 2000. The expanding superfamily of phospholipase A2 enzymes: classification and characterization. Biochim. Biophys. Acta. 1488: 1-19.
16. Blank, M. L., T. C. Lee, V. Fitzgerald, and F. Snyder. 1981. A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). J. Biol. Chem. 256: 175-178.
17. Stafforini, D. M., T. M. McIntyre, M. E. Carter, and S. M. Prescott. 1987. Human plasma platelet-activating factor acetylhydrolase: association with lipoprotein particles and role in the degradation of platelet-activating factor. J. Biol. Chem. 262: 4215-4222.
18. Stremler, K. E., D. M. Stafforini, S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. 1989. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. J. Biol. Chem. 264: 5331-5334.
19. Liu, M., and P. V. Subbaiah. 1994. Hydrolysis and transesterification of platelet-activating factor by lecithin-cholesterol acyltransferase. Proc. Natl. Acad. Sci. USA. 91: 6035-6039.
20. Tsoukatos, D. C., T. A. Liapikos, A. D. Tselepis, M. J. Chapman, and E. Ninio. 2001. Platelet-activating acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein. Biochem. J. 357: 457-464.
21. Liapikos, T. A., S. Antonopoulou, S-A. P. Karabina, D. C. Tsoukatos, C. A. Demopoulos, and A. D. Tselepis. 1994. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated. Biochim. Biophys. Acta. 1212: 353-360.
22. Dentan, C., P. Lesnik, M. J. Chapman, and E. Ninio. 1994. PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by cooper- and cell-mediated oxidation. Arterioscler. Thromb. 14: 353-360.
23. Karabina, S. A, P., T. A. Liapikos, G. Grekas, J. Goudevenos, and A. D. Tselepis. 1994. Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractions. Biochim. Biophys. Acta. 1213: 34-38.
24. Tselepis, A. D., C. Dentan, S. A. P. Karabina, M. J. Chapman, and E. Ninio. 1995. PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme. Arterioscler. Thromb. Vasc. Biol. 15: 1764-1773.
25. Tsoukatos, D. C., M. Arborati, T. A. Liapikos, K. L. Clay, R. C. Murphy, J. M. Chapman, and E. Ninio. 1997. Cooper-catalyzed oxidation mediates PAF formation in human LDL subspecies: protective role of PAF acetylhydrolase in dense LDL. Arterioscler. Thromb. Vasc. Biol. 17: 3505-3512.
26. Marathe, G. K., S. S. Davies, K. A. Harrison, A. R. Silva, R. C. Murphy, H. Castro-Faria-Neto, S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. 1999. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines. J. Biol. Chem. 274: 28395-28404.
27. Lekka, M. E., D. C. Tsoukatos, A. D. Tselepis, and V. M. Kapoulas. 1988. Semisynthetic preparation of 1-O-hexadecyl-2-acetyl-sn-glyceryl-3- phosphorylcholine (platelet-activating factor). Z. Naturforsch. 43c: 665-670.
28. Barlett, G. R. 1959. Phosphorus assay in column chromatography. J. Biol. Chem. 234: 466-468.
29. Marinetti, G. V. 1962. Chromatographic separation, identification and analysis of phosphatidates. J. Lipid Res. 3: 1-28.
30. Kelley, J. L., and P. Alaupovic. 1976. Lipid transport in the avian species. Part I. Isolation and characterization of apolipoproteins and major lipoprotein density classes of male turkey serum. Atherosclerosis. 24: 155-175.
31. Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85.
32. Dentan, C., A. D. Tselepis, M. J. Chapman, and E. Ninio. 1996. Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase. Biochim. Biophys. Acta. 1299: 353-357.
33. Morel, D. W., J. R. Hessler, and G. M. Chilsom. 1983. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipids. J Lipid Res. 24: 1070-1076.
34. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
35. Bossant, M. J., E. Ninio, D. Delautier, and J. Benveniste. 1990. Bioassay of paf-acether by rabbit platelet aggregation. Methods Enzymol. 187: 125-130.
36. Benveniste, J., J-P. Le Couedic, J. Polonsky, and M. Tence. 1977. Structural analysis of purified platelet-activating factor by upases. Nature. 269: 170-171.
37. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450.
38. Clay, K. L., C. Johnson, and S. Worthen. 1991. Biosynthesis of platelet activating factor and 1-0-acyl analogues by endothelial cells. Biochim. Biophys. Acta. 1094: 43-50.
39. Mac Manus, L. M., D. S. Woodward, S. I. Deavers, and R. N. Pinckard. 1993. Biology of disease. PAF molecular heterogeneity: pathobiological implications. Lab. Invest. 69: 639-650.
40. Voelkel, N. F., J. Simpson, S. Worthen, J. T. Reeves, P. M. Henson, and R. C. Murphy. 1983. Platelet-activating factor causes pulmonary vasoconstriction and edema via platelet-independent leukotriene formation. Adv. Prostaglandin Thromboxane Leukot. Res. 12: 179-183.
41. Frankel, E. N. 1998. Lipid Oxidation. The Oily Press, Dundee, UK.
42. Mlakar, A., and G. Spiteller. 1994. Reinvestigation of lipid peroxidation of linolenic acid. Biochim. Biophys. Acta. 1214: 209-212.
43. Frankel, E. N. 1987. Secondary products of lipid oxidation. Chem. Phys. Lipids. 44: 73-85.
44. Tokumura, A., T. Sumida, M. Toujima, K. Kogure, K. Fukuzawa, Y. Takahashi, and S. Yamamoto. 2000. Structural identification of phosphatidylcholines having an oxidatively shortened linoleate residue generated through its oxygenation with soybean or rabbit reticulocyte lipoxygenase. J. Lipid Res. 41: 953-962.
45. Balci, M. 1981. Bicyclic endoperoxides and synthetic applications. Chem. Rev. 81: 91-108.
46. Yla-Herttuala, S., H. Sumuvuori, K. Karkola, M. Mottonen, and T. Nikk. 1987. Atherosclerosis and biochemical composition of coronary arteries in Finish men. Atherosclerosis. 65: 109-115.